Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS

Y Mei1, B Zhao1, A A Basiorka2

  • 1Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Leukemia
|December 22, 2017
PubMed

Insights

Dual deficiency of mDia1 and miR-146a in mice causes anemia mimicking myelodysplastic syndromes (MDS). Ageing bone marrow and inflammation contribute to ineffective erythropoiesis, which was reversed by all-trans retinoic acid treatment.

Area of Science:

  • Hematology
  • Genetics
  • Immunology

Background:

  • Anemia is a hallmark of myelodysplastic syndromes (MDS), but its underlying mechanisms remain poorly understood.
  • Chromosome 5q deletions are common in MDS, often involving genes like mDia1 and miR-146a.

Purpose of the Study:

  • To investigate the role of mDia1 and miR-146a deficiency in MDS pathogenesis.
  • To elucidate the mechanisms of anemia and ineffective erythropoiesis in a mouse model.

Main Methods:

  • A mouse genetic model with dual deficiency of mDia1 and miR-146a was utilized.
  • Age-related bone marrow microenvironment changes and inflammatory responses were analyzed.
  • The effects of all-trans retinoic acid on the disease phenotype were evaluated.

Main Results:

  • Mice with mDia1/miR-146a deficiency developed age-related anemia and ineffective erythropoiesis, mirroring human del(5q) MDS.
  • Ageing bone marrow microenvironment and damage-associated molecular patterns (DAMPs) induced TNFα and IL-6 in myeloid-derived suppressor cells (MDSCs).
  • Pathologic TNFα and IL-6 levels inhibited erythroid formation and promoted apoptosis, leading to anemia.

Conclusions:

  • Combined genetic abnormalities (mDia1/miR-146a deficiency) and an ageing microenvironment are critical in del(5q) MDS pathogenesis.
  • Inflammatory mediators like TNFα and IL-6 play a key role in ineffective erythropoiesis.
  • Targeting MDSC differentiation and inflammation, as with all-trans retinoic acid, can ameliorate MDS-related anemia.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K